Arthritis Market Research Reports & Industry Analysis
Rheumatoid arthritis (RA) is a systemic inflammatory disease. In the United States, approximately a single percent of the population is affected. Women are two to three times more likely to develop rheumatoid arthritis than men, with peak incidence between the fourth and sixth decades. Gender difference disappears in older age. Rheumatoid arthritis affects all races, and its prevalence is not affected by climate. Eighty percent of rheumatoid arthritis patients test rheumatoid factor (RF) positive.
Arthritis Industry Research & Market Reports
-
Anti-inflammatory Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Nonsteroidal Anti-inflammatory Diseases (NSAIDs), Corticosteroids, Biologics), By Indication (Arthritis, Respiratory Disease, Multiple Sclerosis, Psoriasis, Anti-inflammatory Bowel Disease (IBD), Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Anti-inflammatory Therapeutics market size is poised to register 6.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Canine Arthritis Treatment Market Size, Trends, Analysis, and Outlook By Type (Surgery, Drugs, Others), By Route of Administration (Oral, Parenteral, Others), By Treatment (Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells, Autologous Stem Cells), By End-User (Hospitals, Speciality Clinics, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Stem Cells), By End-User (Hospitals, Speciality Clinics, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Canine Arthritis Treatment market size is poised to register 6.84% ... Read More
-
Orthobiologics Market Assessment, By Product [Demineralized Bone Matrix, Viscosupplements, Synthetic Bone Substitutes, Allografts, Bone Growth Factors, Others], By Application [Reconstructive and Fracture Surgery, Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Soft Tissue Repair, Maxillofacial and Dental, Others], By End-user [Hospitals, Ambulatory and Trauma Care Centers, Orthopedic Clinics, Dental Clinics and Facilities, Others], By Region, Opportunities and Forecast, 2017-2031F
... Others], By End-user [Hospitals, Ambulatory and Trauma Care Centers, Orthopedic Clinics, Dental Clinics and Facilities, Others], By Region, Opportunities and Forecast, 2017-2031F Global orthobiologics market is projected to witness a CAGR of 6.08% during the ... Read More
-
Tumor Necrosis Factor Inhibitor Drugs Market Size, Trends, Analysis, and Outlook By Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Tumor Necrosis Factor Inhibitor Drugs market size is poised to register 1.73% growth ... Read More
-
Medical Marijuana Market Size, Trends, Analysis, and Outlook By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Medical Marijuana market size is poised to register 21.66% growth from 2024 to 2030, presenting significant growth ... Read More
-
Rheumatoid Arthritis Therapeutics Market Size, Trends, Analysis, and Outlook By Pharmaceuticals Molecule (NSAIDs, Analgesics, DMARDs, Glucocorticoids), By Biopharmaceuticals Molecule (Biologics, Biosimilars), By Sales Channel (Prescription, Over-the-Counter), by Region, Country, Segment, and Companies, 2024-2030
... Rheumatoid Arthritis Therapeutics market size is poised to register 4.95% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Rheumatoid Arthritis Therapeutics market ... Read More
-
Viscosupplementation Market Size, Trends, Analysis, and Outlook By Product (Single, Three, Five Injection), By Application (Knee, Hip Osteoarthritis), By Source (Animal, Non-Animal), By End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Viscosupplementation market size is poised to register 10.39% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Viscosupplementation market ... Read More
-
Geriatric Medicine Market Size, Trends, Analysis, and Outlook By Therapeutics (Analgesic, Antihypertensive, Statins, Antidiabetic, PPI, Anticoagulant, Antipsychotic, Others), By Condition (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory , Others), by Region, Country, Segment, and Companies, 2024-2030
... The global Geriatric Medicine market size is poised to register 7.74% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Geriatric Medicine market ... Read More
-
The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Gout Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Psoriatic Arthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Gout (Chronic Refractory)
... Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review the disease pathophysiology and potential druggable ... Read More
-
Osteoarthritis Drugs Market (Drug Class: Corticosteroids, NSAIDs & Others, and Viscosupplementation Agents; and Route of Administration: Oral, Parenteral, and Topical) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Scope of Report TMR’s report on the global osteoarthritis drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the ... Read More
-
Psoriatic Arthritis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Medical Marijuana Market by Route of Administration (Inhalation, Oral, Topical), Application (Anorexia, Arthritis, Migraine), Distribution Channel - Global Forecast 2024-2030
... to reach USD 15.66 billion in 2024, at a CAGR 9.07% to reach USD 26.16 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Medical Marijuana Market. It offers ... Read More
-
Bioengineered Protein Drugs Market by Drug Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Disease (Arthritis, Autoimmune Disorders, Blood Disorders), End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 415.13 billion in 2024, at a CAGR 7.76% to reach USD 653.35 billion by 2030. Global Bioengineered Protein Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Gout Therapeutics Market by Drug Class (Colchicine, Corticosteroids, NSAIDs), Treatment (Uricosuria Medication, Xanthine Oxidase Inhibitor), Route of Administration, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 3.05 billion in 2024, at a CAGR 10.95% to reach USD 5.70 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Gout Therapeutics ... Read More
-
Osteoarthritis Pain Drug Market by Drug Class (Corticosteriods, NSAIDs, Viscosupplementation), Route of Administration (Oral, Parenteral, Topical), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 8.54 billion in 2024, at a CAGR 6.47% to reach USD 12.47 billion by 2030. Global Osteoarthritis Pain Drug Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Non-opioid Pain Patches Market by Patch Type (Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches), Indication (Arthritis, Back Pain, Fibromyalgia), Distribution - Global Forecast 2024-2030
... in 2023 and expected to reach USD 790.97 million in 2024, at a CAGR 12.88% to reach USD 1,637.77 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Non-opioid ... Read More
-
Osteoarthritis Therapeutics Market by Anatomy (Hand Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis), Drug Type (Analgesics, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs), Route of Administration, Purchasing Pattern, Distribution Channel
... estimated at USD 7.90 billion in 2023 and expected to reach USD 8.69 billion in 2024, at a CAGR 10.39% to reach USD 15.78 billion by 2030. Global Osteoarthritis Therapeutics Market FPNV Positioning Matrix The ... Read More
Research Assistance
